Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Safety Information For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Kanamycin Injection USP, 500 mg/2 mL & 1 g/3 mL, American Pharmaceutical Partners, ANDA 65-111 KANAMYCIN SULFATE Capsule; 500MG BASE KANTREX APOTHECON 065111 KANAMYCIN SULFATE Injection 1GM BASE/3ML KANAMYCIN AM PARTNERS 065111 KANAMYCIN SULFATE Injection 500MG BASE/2ML KANAMYCIN AM PARTNERS 061901 KANAMYCIN SULFATE Injection 1GM BASE/3ML KANTREX APOTHECON 061901 KANAMYCIN SULFATE Injection 500MG BASE/2ML KANTREX APOTHECON 061901 KANAMYCIN SULFATE Injection 75MG BASE/2ML KANTREX APOTHECON ^ FDA's latest approval appears at the bottom of this list. ^                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | Best Phone © 2012 Betterchem.com